Making a difference to the people we help treat by creating value and improving healthcare outcomes through connecting innovative manufacturers with Australasian customers.

New Vircell SARS-CoV-2 Real Time PCR Kit

Products are for professional/laboratory use only.   Vircell have launched their Real Time RT-PCR kit to detect nucleic acid from SARS-CoV-2 in human respiratory samples. Lyophilized, ready-to-use format, compatible with common open thermocyclers.

Product Description:  SARS-COV-2 REAL TIME PCR KIT
Reference:  RTPCR001
Content: 48 tests

Product Features:

  • Universal kit – suitable to use with any qPCR cycler with FAM/HEX (VIC) detection.
  • Double target assay: specific for COVID-19 (N gene) and other SARS-related coronavirus (E gene).
  • Endogenous human RNAse P control.
  • Fast and reliable results in 90 minutes.
  • No cross reaction with common human respiratory CoV or MERS.
  • Lyophilized presentation to ensure stability and reduce transportation costs.
  • In compliance with international guidelines: WHO, CDC and ECDC.

Find out more about Vircell RT-PCR SARS-CoV-2 Kit

Download Flyer >

View Vircell RT-PCR SARS CoV-2 Kit Insert Sheet

Download Now >

Contact us for a quote

Contact Us Now >



Request a Quote

Request Quote

Recent Posts

Fungal Infection – Assays and Controls*

IMMY | Vircell IMMY’s rapid fungal assays and Vircell’s external controls deliver reliable, room temperature diagnostics with built-in quality assurance for streamlined serology workflows. Vircell…

Read full article

Vircell – VirClia Extraction Tube

Discover Vircell’s VirClia Extraction Tube, an innovative pre-dispensed tube featuring a one-step filtering process that eliminates the need for centrifugation, thereby significantly simplifying the pre-analytical…

Read full article

Advancing Sepsis Diagnostics—Journal of Clinical Medicine (JCM), Honors SeptiCyte RAPID* Study

  Immunexpress are delighted to announce that the study, “Validation of SeptiCyte® RAPID to Discriminate Sepsis from Non-Infectious Systemic Inflammation,” has been selected as an Editor’s Choice Paper for 2024 by the Journal of Clinical Medicine (JCM) MDPI Editorial Team. This honour…

Read full article